| HMGB1: a common biomarker and potential target for TBI, neuroinflammation, epilepsy, and cognitive dysfunction YN Paudel, MF Shaikh, A Chakraborti, Y Kumari, Á Aledo-Serrano, ... Frontiers in neuroscience 12, 628, 2018 | 273 | 2018 |
| AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders V Salpietro, CL Dixon, H Guo, OD Bello, J Vandrovcova, S Efthymiou, ... Nature communications 10 (1), 3094, 2019 | 223 | 2019 |
| Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s disease (AD): from risk factors to therapeutic targeting YN Paudel, E Angelopoulou, C Piperi, I Othman, K Aamir, MF Shaikh Cells 9 (2), 383, 2020 | 200 | 2020 |
| Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling YN Paudel, E Angelopoulou, C Piperi, VRMT Balasubramaniam, ... European journal of pharmacology 858, 172487, 2019 | 168 | 2019 |
| Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy YN Paudel, MF Shaikh, S Shah, Y Kumari, I Othman European journal of pharmacology 837, 145-155, 2018 | 136 | 2018 |
| Zebrafish: a versatile animal model for fertility research JY Hoo, Y Kumari, MF Shaikh, SM Hue, B Hing BioMed Research International, 2016 | 132 | 2016 |
| Alcohol, aggression, and violence: from public health to neuroscience KV Sontate, M Rahim Kamaluddin, I Naina Mohamed, RMP Mohamed, ... Frontiers in psychology 12, 699726, 2021 | 119 | 2021 |
| Alcohol use disorder, neurodegeneration, Alzheimer’s and Parkinson’s disease: Interplay between oxidative stress, neuroimmune response and excitotoxicity H Kamal, GC Tan, SF Ibrahim, MF Shaikh, IN Mohamed, RMP Mohamed, ... Frontiers in Cellular Neuroscience 14, 282, 2020 | 118 | 2020 |
| Zebrafish as a model for epilepsy-induced cognitive dysfunction: a pharmacological, biochemical and behavioral approach UP Kundap, Y Kumari, I Othman, MF Shaikh Frontiers in pharmacology 8, 515, 2017 | 118 | 2017 |
| Amelioration of cognitive deficit by embelin in a scopolamine-induced Alzheimer’s disease-like condition in a rat model S Bhuvanendran, Y Kumari, I Othman, MF Shaikh Frontiers in Pharmacology 9, 665, 2018 | 107 | 2018 |
| Emerging Neuroprotective effect of Metformin in Parkinson’s disease: A Molecular crosstalk YN Paudel, E Angelopoulou, C Piperi, MF Shaikh, I Othman Pharmacological Research, 104593, 2020 | 90 | 2020 |
| Potential neuroprotective effect of the HMGB1 inhibitor glycyrrhizin in neurological disorders YN Paudel, E Angelopoulou, B Semple, C Piperi, I Othman, MF Shaikh ACS chemical neuroscience 11 (4), 485-500, 2020 | 84 | 2020 |
| High mobility group box 1 (HMGB 1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches YN Paudel, BD Semple, NC Jones, I Othman, MF Shaikh Journal of neurochemistry 151 (5), 542-557, 2019 | 82 | 2019 |
| HMGB1-mediated neuroinflammatory responses in brain injuries: potential mechanisms and therapeutic opportunities YN Paudel, E Angelopoulou, C Piperi, I Othman, MF Shaikh International Journal of Molecular Sciences 21 (13), 4609, 2020 | 80 | 2020 |
| PDXK mutations cause polyneuropathy responsive to pyridoxal 5′‐phosphate supplementation V Chelban, MP Wilson, J Warman Chardon, J Vandrovcova, MN Zanetti, ... Annals of neurology 86 (2), 225-240, 2019 | 73 | 2019 |
| Characterization of anticonvulsant and antiepileptogenic potential of thymol in various experimental models J Sancheti, MF Shaikh, R Chaudhari, G Somani, S Patil, P Jain, S Sathaye Naunyn-Schmiedeberg's archives of pharmacology 387, 59-66, 2014 | 69 | 2014 |
| Plant derived phytocompound, Embelin in CNS disorders: A systematic review IOMFS Uday P. Kundap, Saatheeyavaane Bhuvanendran, Yatinesh Kumari Frontiers in Pharmacology, 2017 | 63 | 2017 |
| Protective effect of natural products against Huntington’s disease: An overview of scientific evidence and understanding their mechanism of action PT Lum, M Sekar, SH Gan, SR Bonam, MF Shaikh ACS chemical neuroscience 12 (3), 391-418, 2021 | 60 | 2021 |
| Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson’s disease: Potential clinical and therapeutic implications E Angelopoulou, YN Paudel, MF Shaikh, C Piperi Pharmacological research 158, 104930, 2020 | 58 | 2020 |
| Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination S Efthymiou, V Salpietro, N Malintan, M Poncelet, Y Kriouile, S Fortuna, ... Brain 142 (10), 2948-2964, 2019 | 58 | 2019 |
Iekhsan OthmanJeffrey Cheah school of Medicine and health SciencesVerificeret mail på monash.edu
